Continuous subcutaneous foslevodopa - foscarbidopa infusion therapy for advanced Parkinson's disease –a single centre experience
2025 · Parkinsonism & Related Disorders · 1 citations
https://doi.org/10.1016/j.parkreldis.2025.107628
D
D. Sambolić
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
D. Sambolić is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat